Human Identification Manufacturers Technological Advancements

Who are the Human Identification Market Top Companies and What are Their Offerings?

Human Identification Market Value Chain Analysis

R&D

• The R&D of human identification focuses on the development of high-throughput genomic technologies and next-generation sequencing platforms.
• Key players: Thermo Fisher Scientific Inc., Promega Corporation.

Clinical Trials and Regulatory Approvals

• The analytical sensitivity, software reliability, genotyping concordance, and profile accuracy are evaluated in the clinical trials and regulatory approvals of human identification.
• Key players: Thermo Fisher Scientific Inc., Promega Corporation.

Patient Support and Services

• Comprehensive genetic counselling, rapid buccal-swab testing, clinical case tracking, and parent-based paternity counselling are provided in the patient support and services of the human identification.
• Key players: Thermo Fisher Scientific Inc., Labcorp.

Recent Developments in the Human Identification Market

• In April 2026, XGEN PGT-X™â€¯was launched by GenEmbryomics Limited and Genomic Prediction, Inc. at the 23rd International Conference on Preimplantation Genetics (PGDIS 2026) in China. It is the world’s first clinical-grade embryo-genome sequencing, which helps in the determination of inherited conditions, pathogenic variants, and de novo mutations.
• In October 2025, Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer, offering fast and scalable sample analysis, was launched by Thermo Fisher Scientific. This platform will accelerate the discoveries in pharmacogenomics and support researchers to cover the widest range of populations for Genome-Wide Association Studies (GWAS).

Market Growth

The global human identification market size was estimated at USD 2.94 billion in 2025 and is predicted to increase from USD 3.17 billion in 2026 to approximately USD 6.25 billion by 2035, expanding at a CAGR of 7.84% from 2026 to 2035.